KYMERA THERAPEUTICS, INC. Other Nonoperating Expense
KYMERA THERAPEUTICS, INC. (KYMR) reported Other Nonoperating Expense of $81.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2026-08-05
- KYMERA THERAPEUTICS, INC. other nonoperating expense for the quarter ending 2026-06-30 was $81.00K, a 25.00% decline year-over-year.
- KYMERA THERAPEUTICS, INC. other nonoperating expense for the quarter ending 2026-03-31 was $61.00K, a 15.28% decline year-over-year.
- KYMERA THERAPEUTICS, INC. other nonoperating expense for the quarter ending 2025-12-31 was $90.00K, a 52.54% increase year-over-year.
- KYMERA THERAPEUTICS, INC. other nonoperating expense for the quarter ending 2025-09-30 was $98.00K, a 63.33% increase year-over-year.
- KYMERA THERAPEUTICS, INC. other nonoperating expense for fiscal 2025 was $370.00K, a 48.59% increase from fiscal 2024.
- KYMERA THERAPEUTICS, INC. other nonoperating expense for fiscal 2024 was $249.00K, a 27.04% increase from fiscal 2023.
- KYMERA THERAPEUTICS, INC. other nonoperating expense for fiscal 2023 was $196.00K, a 11.36% increase from fiscal 2022.
- KYMERA THERAPEUTICS, INC. other nonoperating expense for fiscal 2022 was $176.00K, a 0.57% increase from fiscal 2021.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $81.00K 10-Q · filed 2026-08-05 | $141.00K 10-Q · filed 2026-08-05 | $232.00K derived: sum of 3 quarters · filed 2026-08-05 | $330.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $61.00K 10-Q · filed 2026-04-30 | $151.00K derived: sum of 2 quarters · filed 2026-04-30 | $249.00K derived: sum of 3 quarters · filed 2026-04-30 | $357.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $188.00K derived: sum of 2 quarters · filed 2026-02-26 | $296.00K derived: sum of 3 quarters · filed 2026-08-05 | $370.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $98.00K 10-Q · filed 2025-11-04 | $206.00K derived: sum of 2 quarters · filed 2026-08-05 | $280.00K 10-Q · filed 2025-11-04 | $337.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $108.00K 10-Q · filed 2026-08-05 | $180.00K 10-Q · filed 2026-08-05 | $239.00K derived: sum of 3 quarters · filed 2026-08-05 | $299.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $72.00K 10-Q · filed 2026-04-30 | $131.00K derived: sum of 2 quarters · filed 2026-04-30 | $191.00K derived: sum of 3 quarters · filed 2026-04-30 | $252.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $119.00K derived: sum of 2 quarters · filed 2026-02-26 | $180.00K derived: sum of 3 quarters · filed 2026-02-26 | $249.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $60.00K 10-Q · filed 2025-11-04 | $121.00K derived: sum of 2 quarters · filed 2025-11-04 | $190.00K 10-Q · filed 2025-11-04 | $242.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $61.00K 10-Q · filed 2025-08-11 | $131.00K 10-Q · filed 2025-08-11 | $182.00K derived: sum of 3 quarters · filed 2026-02-26 | $223.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $69.00K 10-Q · filed 2025-05-09 | $121.00K derived: sum of 2 quarters · filed 2026-02-26 | $162.00K derived: sum of 3 quarters · filed 2026-02-26 | $210.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $93.00K derived: sum of 2 quarters · filed 2026-02-26 | $141.00K derived: sum of 3 quarters · filed 2026-02-26 | $196.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $41.00K 10-Q · filed 2024-10-31 | $89.00K derived: sum of 2 quarters · filed 2024-10-31 | $144.00K 10-Q · filed 2024-10-31 | $203.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $48.00K 10-Q · filed 2024-08-07 | $103.00K 10-Q · filed 2024-08-07 | $162.00K derived: sum of 3 quarters · filed 2025-02-27 | $198.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $55.00K 10-Q · filed 2024-05-02 | $114.00K derived: sum of 2 quarters · filed 2025-02-27 | $150.00K derived: sum of 3 quarters · filed 2025-02-27 | $191.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $95.00K derived: sum of 2 quarters · filed 2025-02-27 | $136.00K derived: sum of 3 quarters · filed 2025-02-27 | $176.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $36.00K 10-Q · filed 2023-11-02 | $77.00K derived: sum of 2 quarters · filed 2023-11-02 | $117.00K 10-Q · filed 2023-11-02 | $169.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $41.00K 10-Q · filed 2023-08-03 | $81.00K 10-Q · filed 2023-08-03 | $133.00K derived: sum of 3 quarters · filed 2024-02-22 | $203.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $41.00K 10-Q · filed 2023-05-04 | $92.00K derived: sum of 2 quarters · filed 2024-02-22 | $162.00K derived: sum of 3 quarters · filed 2024-02-22 | $190.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $121.00K derived: sum of 2 quarters · filed 2024-02-22 | $149.00K derived: sum of 3 quarters · filed 2024-02-22 | $175.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | $70.00K 10-Q · filed 2022-11-03 | $98.00K derived: sum of 2 quarters · filed 2022-11-03 | $124.00K 10-Q · filed 2022-11-03 | $149.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $28.00K 10-Q · filed 2022-08-09 | $53.00K 10-Q · filed 2022-08-09 | $79.00K derived: sum of 3 quarters · filed 2023-02-23 | $107.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $24.00K 10-Q · filed 2022-05-03 | $51.00K derived: sum of 2 quarters · filed 2023-02-23 | $79.00K derived: sum of 3 quarters · filed 2023-02-23 | $104.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $55.00K derived: sum of 2 quarters · filed 2023-02-23 | $80.00K derived: sum of 3 quarters · filed 2023-02-23 | $115.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $28.00K 10-Q · filed 2021-11-10 | $53.00K derived: sum of 2 quarters · filed 2021-11-10 | $88.00K 10-Q · filed 2021-11-10 | $117.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $25.00K 10-Q · filed 2021-08-06 | $59.00K 10-Q · filed 2021-08-06 | $89.00K derived: sum of 3 quarters · filed 2022-02-24 | $93.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $34.00K 10-Q · filed 2021-05-06 | $64.00K derived: sum of 2 quarters · filed 2022-02-24 | $68.00K derived: sum of 3 quarters · filed 2022-02-24 | |
| 2019-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $34.00K derived: sum of 2 quarters · filed 2022-02-24 | $46.00K 10-K · filed 2022-02-24 | |
| 2019-09-30 | $4.00K 10-Q · filed 2020-11-05 | $16.00K 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |